The mammalian target of rapamycin provides the female rodent heart sex-dependent resistance to ischemic damage

雷帕霉素的哺乳动物靶标为雌性啮齿动物心脏提供性别依赖性的缺血损伤抵抗力

• 批准号: 407781
• 负责人: Calderone Angelo
• 金额: $ 39.57万
• 依托单位: Montreal Heart Institute
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-09-01 至 2024-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=407781&lang=en
• 关键词: Myocardial Infarction; Sex-Dependent Resistance To Ischemia

It has been well established that the adult female heart has an inherently greater resistance to damage after a reduction of blood flow. Despite these findings, the underlying events providing the female heart greater protections remains equivocal. In add

已经确定的是，成年女性心脏在血流减少后具有固有的更大的抗损伤能力。尽管有这些发现，但为女性心脏提供更大保护的潜在事件仍然模棱两可。在添加